SlideShare a Scribd company logo
Intervention to Reduce Inappropriate
Papanicolaou Testing in a Resident
Clinic
L. Kyle Horton MD, MBA
Samantha H. H. Hudson MD, Meng
Denise L. Borden MD
Arpita Aggarwal MD, MS
Slide 2
Disclosure Statement
Speaker: Kyle Horton MD, MBA
Co-Investigators from VCU Internal Medicine:
Samantha H. H. Hudson MD, Meng
Denise L. Borden MD
Arpita Aggarwal MD
Contributors to Pilot Study
Ajay Patil DO
Amy Anderson DO, MPH
Neither the speaker nor any co-investigators have any relevant disclosures
to make.
Slide 3
Background
• Guideline-inconsistent cancer screening is
prevalent
-Yabroff et al survey regarding Papanicolaou
testing published in Annals 2006 to 2007
*Internists only guideline-consistent 27.5% of
time
-Yabroff et al regarding colorectal cancer
screening
*Only 19.1% of providers guideline-consistent
Yabroff et al. Ann Int Med. 2009; 151: 602-611
Yabroff et al. J Gen Intern Med. 2010; 10.1007
Slide 4
VCU IM Resident Clinic
• Internal Medicine and Med/Peds Residents
-Continuity clinic 1/2 day per week
• Diverse Population
– Urban and Rural
– Largely underserved
– Often under- or non-insured
Slide 5
Over-screening for Cervical Cancer
• Noted over-screening for cervical cancer in our
resident clinic
• Conflicting Guidelines
-American College of Obstetrics and Gynecology
(ACOG)
-United States Preventive Services Task Force
(USPSTF)
-American Cancer Society (ACS)
• Residents have varied training/backgrounds
-Family Medicine, Internal Medicine, and OB/Gyn
Slide 6
Pilot Study
#
83%
14%
2%
1%
17%
Appropriate Post-Hyst > age 65 Post-Hyst and > age 65
Slide 7
Aim
Aim: Design and implement an intervention to
improve
-Understanding of guidelines
-Adherence to guidelines
Goal: achieve 95% adherence to USPSTF
cervical cancer screening guidelines
Slide 8
Intervention Plan
• Created a “Pap Clinic” held 1/2 day per week
-For focused Women’s Health Visits
-Created an Electronic Medical Record
Template Note
*Highlights relevant Gyn history
*Incorporates the USPSTF guidelines
*Includes a follow-up plan for further
screening
Slide 9
Methods
• Pilot Study-229 charts assessed for
appropriateness
• Implemented the “Pap Clinic”
• Retrospectively reviewed 119 charts from
“Pap Clinic”
• Univariate and bivariate analyses: means,
Fisher exact, and ANOVA tests
• SAS 9.2 statistical software
• P-value <0.05 was considered statistically
significant
Slide 10
Demographics
Pilot Post-Intervention
Age
Average 51.4 50.8
Inappropriate 60.3 73.5
Race
African-American 69.9% 68.9%
Caucasian 28.4% 30.3%
Other 1.7% 0.8%
Insurance
Medicare 32.3% 38.7%
Private 22.7% 11.8%
Indigent 26.2% 30.3%
Self-Pay 15.3% 10.9%
Other 3.5% 8.4%
Slide 11
Results
Pre-Intervention vs. Post-Intervention
17.0% Inappropriate
(229 Total Patients)
1.7% Inappropriate
(119 Total Patients)
Statistically significant decrease in inappropriate Paps
(Fisher Exact Test p<0.0001)
Inappropriate
Appropriate
Slide 12
Limitations
• Results may lack generalizability
-Interns more easily molded by intervention
• May reflect selection bias to referred patients
• Small sample size post-intervention
• Too early to assess for overall effect
-Not all of current residents rotated through
the “Pap Clinic”
-Still 16.8% inappropriate referrals
Slide 13
Conclusions
• Creating a clinic for focused women’s health visits
using an electronic medical record template was
effective at reducing inappropriate Pap testing
• The Future: Data re-analysis for broader efficacy
once all trainees have rotated through the clinic
• Implication: creating electronic medical record
templates and focusing women’s health visits may
prove to be an effective way to improve compliance
with Pap testing guidelines in primary care
Slide 14
Questions?
THE WALL STREET JOURNAL 2/15/2011
“Questioning the Need For Routine Pelvic Exam”
By Melinda Beck
“Of all the indignities that women endure in their
lives, one of the most dreaded is the routine
pelvic exam.”
-Based on commentary Journal of Women’s
Health
-Article makes reference to the new ACOG
guidelines recommending Pap every 2 years
for women age 21 to 30 and 3 years 30 for
older

More Related Content

What's hot

0405 Bettina Rryll - The clinical trials we want!
0405  Bettina Rryll - The clinical trials we want! 0405  Bettina Rryll - The clinical trials we want!
0405 Bettina Rryll - The clinical trials we want!
Workgroup of European Cancer Patient Advocacy Networks
 
Rules of Engagement in Drug Development: Activating the Patient Voice
Rules of Engagement in Drug Development: Activating the Patient VoiceRules of Engagement in Drug Development: Activating the Patient Voice
Rules of Engagement in Drug Development: Activating the Patient Voice
National Alopecia Areata Foundation
 
Predictors of MDT review and the impact on lung cancer survival for HNELHD re...
Predictors of MDT review and the impact on lung cancer survival for HNELHD re...Predictors of MDT review and the impact on lung cancer survival for HNELHD re...
Predictors of MDT review and the impact on lung cancer survival for HNELHD re...
Cancer Institute NSW
 
Genetic testing evaluation part 1 2018
Genetic testing evaluation part 1 2018Genetic testing evaluation part 1 2018
Genetic testing evaluation part 1 2018
John Shoffner, MD
 
group 6 Poster 409
group 6 Poster 409group 6 Poster 409
group 6 Poster 409
Adrian Anderson
 
Steury.dissertation presentation2014
Steury.dissertation presentation2014Steury.dissertation presentation2014
Steury.dissertation presentation2014
nesteury
 
No 3 tue 0800 clanon tue universal testing atlanta kac pro 2
No 3 tue 0800 clanon tue universal testing atlanta kac pro 2No 3 tue 0800 clanon tue universal testing atlanta kac pro 2
No 3 tue 0800 clanon tue universal testing atlanta kac pro 2
CDC NPIN
 
Poster-v9 (Steven Asbill, TOC)
Poster-v9 (Steven Asbill, TOC)Poster-v9 (Steven Asbill, TOC)
Poster-v9 (Steven Asbill, TOC)
Min Song, PharmD, BCPS
 
5.+keynote o donnell
5.+keynote o donnell5.+keynote o donnell
5.+keynote o donnell
emadayad7
 
Comorbidities Present in the Alopecia Areata Registry, Biobank & Clinical Tri...
Comorbidities Present in the Alopecia Areata Registry, Biobank & Clinical Tri...Comorbidities Present in the Alopecia Areata Registry, Biobank & Clinical Tri...
Comorbidities Present in the Alopecia Areata Registry, Biobank & Clinical Tri...
National Alopecia Areata Foundation
 
2004 Cancer SOS paper
2004 Cancer SOS paper2004 Cancer SOS paper
2004 Cancer SOS paper
Jennifer Schroeder
 
AACP_2015_SurveyPoster_Sayre
AACP_2015_SurveyPoster_SayreAACP_2015_SurveyPoster_Sayre
AACP_2015_SurveyPoster_Sayre
Franklin Sayre
 
The Effect of Electronic Medical Record Alerts on Processes of Care Related t...
The Effect of Electronic Medical Record Alerts on Processes of Care Related t...The Effect of Electronic Medical Record Alerts on Processes of Care Related t...
The Effect of Electronic Medical Record Alerts on Processes of Care Related t...
Leonard Davis Institute of Health Economics
 
0107 Jan Geissler - How drug development works and elements of trial protocols
0107 Jan Geissler - How drug development works and elements of trial protocols0107 Jan Geissler - How drug development works and elements of trial protocols
0107 Jan Geissler - How drug development works and elements of trial protocols
Workgroup of European Cancer Patient Advocacy Networks
 
Results of an Online Survey of Stakeholders Regarding Barriers and Solutions ...
Results of an Online Survey of Stakeholders Regarding Barriers and Solutions ...Results of an Online Survey of Stakeholders Regarding Barriers and Solutions ...
Results of an Online Survey of Stakeholders Regarding Barriers and Solutions ...
John Reites
 
Clinical Trial Recruitment
Clinical Trial RecruitmentClinical Trial Recruitment
Clinical Trial Recruitment
Clinical List America
 
Cancer patients’ experiences in one tertiary referral emergency department (E...
Cancer patients’ experiences in one tertiary referral emergency department (E...Cancer patients’ experiences in one tertiary referral emergency department (E...
Cancer patients’ experiences in one tertiary referral emergency department (E...
Cancer Institute NSW
 
0306 2 Madelaine Pe - Analysing and Comparing PRO
0306 2 Madelaine Pe - Analysing and Comparing PRO0306 2 Madelaine Pe - Analysing and Comparing PRO
0306 2 Madelaine Pe - Analysing and Comparing PRO
Workgroup of European Cancer Patient Advocacy Networks
 
PMED: APPM Workshop: Challenges in Using Bayesian Analysis Approaches for Reg...
PMED: APPM Workshop: Challenges in Using Bayesian Analysis Approaches for Reg...PMED: APPM Workshop: Challenges in Using Bayesian Analysis Approaches for Reg...
PMED: APPM Workshop: Challenges in Using Bayesian Analysis Approaches for Reg...
The Statistical and Applied Mathematical Sciences Institute
 
Valuing the EQ-5D-Y Using a Discrete Choice Experiment: Do Adult and Adolesce...
Valuing the EQ-5D-Y Using a Discrete Choice Experiment: Do Adult and Adolesce...Valuing the EQ-5D-Y Using a Discrete Choice Experiment: Do Adult and Adolesce...
Valuing the EQ-5D-Y Using a Discrete Choice Experiment: Do Adult and Adolesce...
Office of Health Economics
 

What's hot (20)

0405 Bettina Rryll - The clinical trials we want!
0405  Bettina Rryll - The clinical trials we want! 0405  Bettina Rryll - The clinical trials we want!
0405 Bettina Rryll - The clinical trials we want!
 
Rules of Engagement in Drug Development: Activating the Patient Voice
Rules of Engagement in Drug Development: Activating the Patient VoiceRules of Engagement in Drug Development: Activating the Patient Voice
Rules of Engagement in Drug Development: Activating the Patient Voice
 
Predictors of MDT review and the impact on lung cancer survival for HNELHD re...
Predictors of MDT review and the impact on lung cancer survival for HNELHD re...Predictors of MDT review and the impact on lung cancer survival for HNELHD re...
Predictors of MDT review and the impact on lung cancer survival for HNELHD re...
 
Genetic testing evaluation part 1 2018
Genetic testing evaluation part 1 2018Genetic testing evaluation part 1 2018
Genetic testing evaluation part 1 2018
 
group 6 Poster 409
group 6 Poster 409group 6 Poster 409
group 6 Poster 409
 
Steury.dissertation presentation2014
Steury.dissertation presentation2014Steury.dissertation presentation2014
Steury.dissertation presentation2014
 
No 3 tue 0800 clanon tue universal testing atlanta kac pro 2
No 3 tue 0800 clanon tue universal testing atlanta kac pro 2No 3 tue 0800 clanon tue universal testing atlanta kac pro 2
No 3 tue 0800 clanon tue universal testing atlanta kac pro 2
 
Poster-v9 (Steven Asbill, TOC)
Poster-v9 (Steven Asbill, TOC)Poster-v9 (Steven Asbill, TOC)
Poster-v9 (Steven Asbill, TOC)
 
5.+keynote o donnell
5.+keynote o donnell5.+keynote o donnell
5.+keynote o donnell
 
Comorbidities Present in the Alopecia Areata Registry, Biobank & Clinical Tri...
Comorbidities Present in the Alopecia Areata Registry, Biobank & Clinical Tri...Comorbidities Present in the Alopecia Areata Registry, Biobank & Clinical Tri...
Comorbidities Present in the Alopecia Areata Registry, Biobank & Clinical Tri...
 
2004 Cancer SOS paper
2004 Cancer SOS paper2004 Cancer SOS paper
2004 Cancer SOS paper
 
AACP_2015_SurveyPoster_Sayre
AACP_2015_SurveyPoster_SayreAACP_2015_SurveyPoster_Sayre
AACP_2015_SurveyPoster_Sayre
 
The Effect of Electronic Medical Record Alerts on Processes of Care Related t...
The Effect of Electronic Medical Record Alerts on Processes of Care Related t...The Effect of Electronic Medical Record Alerts on Processes of Care Related t...
The Effect of Electronic Medical Record Alerts on Processes of Care Related t...
 
0107 Jan Geissler - How drug development works and elements of trial protocols
0107 Jan Geissler - How drug development works and elements of trial protocols0107 Jan Geissler - How drug development works and elements of trial protocols
0107 Jan Geissler - How drug development works and elements of trial protocols
 
Results of an Online Survey of Stakeholders Regarding Barriers and Solutions ...
Results of an Online Survey of Stakeholders Regarding Barriers and Solutions ...Results of an Online Survey of Stakeholders Regarding Barriers and Solutions ...
Results of an Online Survey of Stakeholders Regarding Barriers and Solutions ...
 
Clinical Trial Recruitment
Clinical Trial RecruitmentClinical Trial Recruitment
Clinical Trial Recruitment
 
Cancer patients’ experiences in one tertiary referral emergency department (E...
Cancer patients’ experiences in one tertiary referral emergency department (E...Cancer patients’ experiences in one tertiary referral emergency department (E...
Cancer patients’ experiences in one tertiary referral emergency department (E...
 
0306 2 Madelaine Pe - Analysing and Comparing PRO
0306 2 Madelaine Pe - Analysing and Comparing PRO0306 2 Madelaine Pe - Analysing and Comparing PRO
0306 2 Madelaine Pe - Analysing and Comparing PRO
 
PMED: APPM Workshop: Challenges in Using Bayesian Analysis Approaches for Reg...
PMED: APPM Workshop: Challenges in Using Bayesian Analysis Approaches for Reg...PMED: APPM Workshop: Challenges in Using Bayesian Analysis Approaches for Reg...
PMED: APPM Workshop: Challenges in Using Bayesian Analysis Approaches for Reg...
 
Valuing the EQ-5D-Y Using a Discrete Choice Experiment: Do Adult and Adolesce...
Valuing the EQ-5D-Y Using a Discrete Choice Experiment: Do Adult and Adolesce...Valuing the EQ-5D-Y Using a Discrete Choice Experiment: Do Adult and Adolesce...
Valuing the EQ-5D-Y Using a Discrete Choice Experiment: Do Adult and Adolesce...
 

Viewers also liked

Ismail Khan (06-10-2015)
Ismail Khan (06-10-2015)Ismail Khan (06-10-2015)
Ismail Khan (06-10-2015)
Delhi-42 The DTU Quiz Club
 
Practica de campo
Practica de campoPractica de campo
Practica de campo
Jesus Rodriguez
 
Enthiran mains
Enthiran mainsEnthiran mains
Enthiran mains
Remya Roshni
 
Anwesha Chattoraj (14-01-2016)
Anwesha Chattoraj (14-01-2016)Anwesha Chattoraj (14-01-2016)
Anwesha Chattoraj (14-01-2016)
Delhi-42 The DTU Quiz Club
 
January QOTM
January QOTMJanuary QOTM
Presentacion outsourcing
Presentacion outsourcingPresentacion outsourcing
Presentacion outsourcing
Maria alejandra cañola Estrada
 
QMQ 23/10/16
QMQ 23/10/16QMQ 23/10/16
Intra Quiz Prelims
Intra Quiz PrelimsIntra Quiz Prelims
Intra Quiz Prelims
Quest-SGGSCC
 
Dcac media prelims answers
Dcac media prelims answersDcac media prelims answers
Dcac media prelims answers
ram9419
 
Cognitio - The Gen Quiz Prelims
Cognitio - The Gen Quiz PrelimsCognitio - The Gen Quiz Prelims
Cognitio - The Gen Quiz Prelims
Ritwik Mishra
 
The LSD Quiz - NSIT Quiz Fest 2014
The LSD Quiz - NSIT Quiz Fest 2014The LSD Quiz - NSIT Quiz Fest 2014
The LSD Quiz - NSIT Quiz Fest 2014
nsitqc
 
Gravitas '16 SciBizTech - Prelims
Gravitas '16 SciBizTech - PrelimsGravitas '16 SciBizTech - Prelims
Gravitas '16 SciBizTech - Prelims
DBQC - The VIT Quiz Club
 
Finance and Economics Quiz Finals held at MIT Manipal by ESOM
Finance and Economics Quiz Finals held at MIT Manipal by ESOMFinance and Economics Quiz Finals held at MIT Manipal by ESOM
Finance and Economics Quiz Finals held at MIT Manipal by ESOM
Sandeep Rao
 
General Quiz - From uzbekistan with love by Vahid and Faseel
General Quiz - From uzbekistan with love by Vahid and FaseelGeneral Quiz - From uzbekistan with love by Vahid and Faseel
General Quiz - From uzbekistan with love by Vahid and Faseel
Abdul Vahid
 
Illuminati Freshers General Quiz 2016 Finals
Illuminati Freshers General Quiz 2016 FinalsIlluminati Freshers General Quiz 2016 Finals
Illuminati Freshers General Quiz 2016 Finals
Jigyasa Khattar
 
INTER SCHOOL QUIZ (Prelims+answers) AMU QUIZ CLUB
INTER SCHOOL QUIZ (Prelims+answers) AMU QUIZ CLUBINTER SCHOOL QUIZ (Prelims+answers) AMU QUIZ CLUB
INTER SCHOOL QUIZ (Prelims+answers) AMU QUIZ CLUB
AMU QUIZ CLUB
 
Sports quiz in Bengali Language
Sports quiz in Bengali LanguageSports quiz in Bengali Language
Sports quiz in Bengali Language
Kingsuk Maity
 
India Quiz-NUTech-2016,Nirma University
India Quiz-NUTech-2016,Nirma UniversityIndia Quiz-NUTech-2016,Nirma University
India Quiz-NUTech-2016,Nirma University
MANTRARAJ NAIK
 
Finance Quiz
Finance QuizFinance Quiz
Finance Quiz
Dr. Amit Joshi
 

Viewers also liked (20)

Ismail Khan (06-10-2015)
Ismail Khan (06-10-2015)Ismail Khan (06-10-2015)
Ismail Khan (06-10-2015)
 
Infigo IS
Infigo ISInfigo IS
Infigo IS
 
Practica de campo
Practica de campoPractica de campo
Practica de campo
 
Enthiran mains
Enthiran mainsEnthiran mains
Enthiran mains
 
Anwesha Chattoraj (14-01-2016)
Anwesha Chattoraj (14-01-2016)Anwesha Chattoraj (14-01-2016)
Anwesha Chattoraj (14-01-2016)
 
January QOTM
January QOTMJanuary QOTM
January QOTM
 
Presentacion outsourcing
Presentacion outsourcingPresentacion outsourcing
Presentacion outsourcing
 
QMQ 23/10/16
QMQ 23/10/16QMQ 23/10/16
QMQ 23/10/16
 
Intra Quiz Prelims
Intra Quiz PrelimsIntra Quiz Prelims
Intra Quiz Prelims
 
Dcac media prelims answers
Dcac media prelims answersDcac media prelims answers
Dcac media prelims answers
 
Cognitio - The Gen Quiz Prelims
Cognitio - The Gen Quiz PrelimsCognitio - The Gen Quiz Prelims
Cognitio - The Gen Quiz Prelims
 
The LSD Quiz - NSIT Quiz Fest 2014
The LSD Quiz - NSIT Quiz Fest 2014The LSD Quiz - NSIT Quiz Fest 2014
The LSD Quiz - NSIT Quiz Fest 2014
 
Gravitas '16 SciBizTech - Prelims
Gravitas '16 SciBizTech - PrelimsGravitas '16 SciBizTech - Prelims
Gravitas '16 SciBizTech - Prelims
 
Finance and Economics Quiz Finals held at MIT Manipal by ESOM
Finance and Economics Quiz Finals held at MIT Manipal by ESOMFinance and Economics Quiz Finals held at MIT Manipal by ESOM
Finance and Economics Quiz Finals held at MIT Manipal by ESOM
 
General Quiz - From uzbekistan with love by Vahid and Faseel
General Quiz - From uzbekistan with love by Vahid and FaseelGeneral Quiz - From uzbekistan with love by Vahid and Faseel
General Quiz - From uzbekistan with love by Vahid and Faseel
 
Illuminati Freshers General Quiz 2016 Finals
Illuminati Freshers General Quiz 2016 FinalsIlluminati Freshers General Quiz 2016 Finals
Illuminati Freshers General Quiz 2016 Finals
 
INTER SCHOOL QUIZ (Prelims+answers) AMU QUIZ CLUB
INTER SCHOOL QUIZ (Prelims+answers) AMU QUIZ CLUBINTER SCHOOL QUIZ (Prelims+answers) AMU QUIZ CLUB
INTER SCHOOL QUIZ (Prelims+answers) AMU QUIZ CLUB
 
Sports quiz in Bengali Language
Sports quiz in Bengali LanguageSports quiz in Bengali Language
Sports quiz in Bengali Language
 
India Quiz-NUTech-2016,Nirma University
India Quiz-NUTech-2016,Nirma UniversityIndia Quiz-NUTech-2016,Nirma University
India Quiz-NUTech-2016,Nirma University
 
Finance Quiz
Finance QuizFinance Quiz
Finance Quiz
 

Similar to Horton-SGIM

DFCM Top 5 research studies that will impact clinical practice
DFCM Top 5 research studies that will impact clinical practiceDFCM Top 5 research studies that will impact clinical practice
DFCM Top 5 research studies that will impact clinical practice
Health Quality Ontario (HQO)
 
SGIM Poster-Final
SGIM Poster-FinalSGIM Poster-Final
SGIM Poster-Final
L. Kyle Horton MD, MBA
 
U of T Department of Family & Community Medicine PEARLS 2014
U of T Department of Family & Community Medicine PEARLS 2014U of T Department of Family & Community Medicine PEARLS 2014
U of T Department of Family & Community Medicine PEARLS 2014
Health Quality Ontario (HQO)
 
Screening
ScreeningScreening
Inbuild trial journal club
Inbuild trial  journal clubInbuild trial  journal club
Inbuild trial journal club
MidhunMohanK1
 
Random Clinical Trials
Random Clinical Trials Random Clinical Trials
Random Clinical Trials
Zaina Assaf
 
DFCM Pearls: What is New
DFCM Pearls: What is NewDFCM Pearls: What is New
DFCM Pearls: What is New
Health Quality Ontario (HQO)
 
Appendix by drdamodhar.m.v
Appendix by drdamodhar.m.vAppendix by drdamodhar.m.v
Appendix by drdamodhar.m.v
Dr.Damodhar.M.V MBBS,CSSGB,MBA,CPHQ
 
1 prof james bently cervical cancer screening 2014
1  prof james bently cervical cancer screening 20141  prof james bently cervical cancer screening 2014
1 prof james bently cervical cancer screening 2014
Tariq Mohammed
 
1 prof james bently cervical cancer screening 2014
1  prof james bently cervical cancer screening 20141  prof james bently cervical cancer screening 2014
1 prof james bently cervical cancer screening 2014
Tariq Mohammed
 
Critical appraisal of randomized clinical trials
Critical appraisal of randomized clinical trialsCritical appraisal of randomized clinical trials
Critical appraisal of randomized clinical trials
Samir Haffar
 
Toward Universal HIV Testing:Is the CDC Recommendation of “Opt-out” Screening...
Toward Universal HIV Testing:Is the CDC Recommendation of “Opt-out” Screening...Toward Universal HIV Testing:Is the CDC Recommendation of “Opt-out” Screening...
Toward Universal HIV Testing:Is the CDC Recommendation of “Opt-out” Screening...
CDC NPIN
 
bevacizumab chemotherapy treatment of metastastic colorectal cancer metasta...
 bevacizumab  chemotherapy treatment of metastastic colorectal cancer metasta... bevacizumab  chemotherapy treatment of metastastic colorectal cancer metasta...
bevacizumab chemotherapy treatment of metastastic colorectal cancer metasta...
Мандухай Г.
 
MedicReS Winter School 2017 Vienna - Advanced Clinical Practice in Oncology -...
MedicReS Winter School 2017 Vienna - Advanced Clinical Practice in Oncology -...MedicReS Winter School 2017 Vienna - Advanced Clinical Practice in Oncology -...
MedicReS Winter School 2017 Vienna - Advanced Clinical Practice in Oncology -...
MedicReS
 
Launch of Policy Cures: Improving Access to Diagnostics in the Developing Wor...
Launch of Policy Cures: Improving Access to Diagnostics in the Developing Wor...Launch of Policy Cures: Improving Access to Diagnostics in the Developing Wor...
Launch of Policy Cures: Improving Access to Diagnostics in the Developing Wor...
LIDC
 
Study designs
Study designsStudy designs
Study designs
drjagannath
 
SSHC Journal Club presentation on the British Medical Journal and the Medical...
SSHC Journal Club presentation on the British Medical Journal and the Medical...SSHC Journal Club presentation on the British Medical Journal and the Medical...
SSHC Journal Club presentation on the British Medical Journal and the Medical...
Sydney Sexual Health Centre
 
Biochemical tests in clinical medicine lect1
Biochemical tests in clinical medicine lect1Biochemical tests in clinical medicine lect1
Biochemical tests in clinical medicine lect1
MUDASSAR ANWER
 
IV Jornada. Sp y práctica reflexiva f borrell_pompeu fabra_2011
IV Jornada. Sp y práctica reflexiva f borrell_pompeu fabra_2011IV Jornada. Sp y práctica reflexiva f borrell_pompeu fabra_2011
IV Jornada. Sp y práctica reflexiva f borrell_pompeu fabra_2011
Sano y Salvo
 
Cancer and the General Internist
Cancer and the General InternistCancer and the General Internist
Cancer and the General Internist
LanceCatedral
 

Similar to Horton-SGIM (20)

DFCM Top 5 research studies that will impact clinical practice
DFCM Top 5 research studies that will impact clinical practiceDFCM Top 5 research studies that will impact clinical practice
DFCM Top 5 research studies that will impact clinical practice
 
SGIM Poster-Final
SGIM Poster-FinalSGIM Poster-Final
SGIM Poster-Final
 
U of T Department of Family & Community Medicine PEARLS 2014
U of T Department of Family & Community Medicine PEARLS 2014U of T Department of Family & Community Medicine PEARLS 2014
U of T Department of Family & Community Medicine PEARLS 2014
 
Screening
ScreeningScreening
Screening
 
Inbuild trial journal club
Inbuild trial  journal clubInbuild trial  journal club
Inbuild trial journal club
 
Random Clinical Trials
Random Clinical Trials Random Clinical Trials
Random Clinical Trials
 
DFCM Pearls: What is New
DFCM Pearls: What is NewDFCM Pearls: What is New
DFCM Pearls: What is New
 
Appendix by drdamodhar.m.v
Appendix by drdamodhar.m.vAppendix by drdamodhar.m.v
Appendix by drdamodhar.m.v
 
1 prof james bently cervical cancer screening 2014
1  prof james bently cervical cancer screening 20141  prof james bently cervical cancer screening 2014
1 prof james bently cervical cancer screening 2014
 
1 prof james bently cervical cancer screening 2014
1  prof james bently cervical cancer screening 20141  prof james bently cervical cancer screening 2014
1 prof james bently cervical cancer screening 2014
 
Critical appraisal of randomized clinical trials
Critical appraisal of randomized clinical trialsCritical appraisal of randomized clinical trials
Critical appraisal of randomized clinical trials
 
Toward Universal HIV Testing:Is the CDC Recommendation of “Opt-out” Screening...
Toward Universal HIV Testing:Is the CDC Recommendation of “Opt-out” Screening...Toward Universal HIV Testing:Is the CDC Recommendation of “Opt-out” Screening...
Toward Universal HIV Testing:Is the CDC Recommendation of “Opt-out” Screening...
 
bevacizumab chemotherapy treatment of metastastic colorectal cancer metasta...
 bevacizumab  chemotherapy treatment of metastastic colorectal cancer metasta... bevacizumab  chemotherapy treatment of metastastic colorectal cancer metasta...
bevacizumab chemotherapy treatment of metastastic colorectal cancer metasta...
 
MedicReS Winter School 2017 Vienna - Advanced Clinical Practice in Oncology -...
MedicReS Winter School 2017 Vienna - Advanced Clinical Practice in Oncology -...MedicReS Winter School 2017 Vienna - Advanced Clinical Practice in Oncology -...
MedicReS Winter School 2017 Vienna - Advanced Clinical Practice in Oncology -...
 
Launch of Policy Cures: Improving Access to Diagnostics in the Developing Wor...
Launch of Policy Cures: Improving Access to Diagnostics in the Developing Wor...Launch of Policy Cures: Improving Access to Diagnostics in the Developing Wor...
Launch of Policy Cures: Improving Access to Diagnostics in the Developing Wor...
 
Study designs
Study designsStudy designs
Study designs
 
SSHC Journal Club presentation on the British Medical Journal and the Medical...
SSHC Journal Club presentation on the British Medical Journal and the Medical...SSHC Journal Club presentation on the British Medical Journal and the Medical...
SSHC Journal Club presentation on the British Medical Journal and the Medical...
 
Biochemical tests in clinical medicine lect1
Biochemical tests in clinical medicine lect1Biochemical tests in clinical medicine lect1
Biochemical tests in clinical medicine lect1
 
IV Jornada. Sp y práctica reflexiva f borrell_pompeu fabra_2011
IV Jornada. Sp y práctica reflexiva f borrell_pompeu fabra_2011IV Jornada. Sp y práctica reflexiva f borrell_pompeu fabra_2011
IV Jornada. Sp y práctica reflexiva f borrell_pompeu fabra_2011
 
Cancer and the General Internist
Cancer and the General InternistCancer and the General Internist
Cancer and the General Internist
 

Horton-SGIM

  • 1. Intervention to Reduce Inappropriate Papanicolaou Testing in a Resident Clinic L. Kyle Horton MD, MBA Samantha H. H. Hudson MD, Meng Denise L. Borden MD Arpita Aggarwal MD, MS
  • 2. Slide 2 Disclosure Statement Speaker: Kyle Horton MD, MBA Co-Investigators from VCU Internal Medicine: Samantha H. H. Hudson MD, Meng Denise L. Borden MD Arpita Aggarwal MD Contributors to Pilot Study Ajay Patil DO Amy Anderson DO, MPH Neither the speaker nor any co-investigators have any relevant disclosures to make.
  • 3. Slide 3 Background • Guideline-inconsistent cancer screening is prevalent -Yabroff et al survey regarding Papanicolaou testing published in Annals 2006 to 2007 *Internists only guideline-consistent 27.5% of time -Yabroff et al regarding colorectal cancer screening *Only 19.1% of providers guideline-consistent Yabroff et al. Ann Int Med. 2009; 151: 602-611 Yabroff et al. J Gen Intern Med. 2010; 10.1007
  • 4. Slide 4 VCU IM Resident Clinic • Internal Medicine and Med/Peds Residents -Continuity clinic 1/2 day per week • Diverse Population – Urban and Rural – Largely underserved – Often under- or non-insured
  • 5. Slide 5 Over-screening for Cervical Cancer • Noted over-screening for cervical cancer in our resident clinic • Conflicting Guidelines -American College of Obstetrics and Gynecology (ACOG) -United States Preventive Services Task Force (USPSTF) -American Cancer Society (ACS) • Residents have varied training/backgrounds -Family Medicine, Internal Medicine, and OB/Gyn
  • 6. Slide 6 Pilot Study # 83% 14% 2% 1% 17% Appropriate Post-Hyst > age 65 Post-Hyst and > age 65
  • 7. Slide 7 Aim Aim: Design and implement an intervention to improve -Understanding of guidelines -Adherence to guidelines Goal: achieve 95% adherence to USPSTF cervical cancer screening guidelines
  • 8. Slide 8 Intervention Plan • Created a “Pap Clinic” held 1/2 day per week -For focused Women’s Health Visits -Created an Electronic Medical Record Template Note *Highlights relevant Gyn history *Incorporates the USPSTF guidelines *Includes a follow-up plan for further screening
  • 9. Slide 9 Methods • Pilot Study-229 charts assessed for appropriateness • Implemented the “Pap Clinic” • Retrospectively reviewed 119 charts from “Pap Clinic” • Univariate and bivariate analyses: means, Fisher exact, and ANOVA tests • SAS 9.2 statistical software • P-value <0.05 was considered statistically significant
  • 10. Slide 10 Demographics Pilot Post-Intervention Age Average 51.4 50.8 Inappropriate 60.3 73.5 Race African-American 69.9% 68.9% Caucasian 28.4% 30.3% Other 1.7% 0.8% Insurance Medicare 32.3% 38.7% Private 22.7% 11.8% Indigent 26.2% 30.3% Self-Pay 15.3% 10.9% Other 3.5% 8.4%
  • 11. Slide 11 Results Pre-Intervention vs. Post-Intervention 17.0% Inappropriate (229 Total Patients) 1.7% Inappropriate (119 Total Patients) Statistically significant decrease in inappropriate Paps (Fisher Exact Test p<0.0001) Inappropriate Appropriate
  • 12. Slide 12 Limitations • Results may lack generalizability -Interns more easily molded by intervention • May reflect selection bias to referred patients • Small sample size post-intervention • Too early to assess for overall effect -Not all of current residents rotated through the “Pap Clinic” -Still 16.8% inappropriate referrals
  • 13. Slide 13 Conclusions • Creating a clinic for focused women’s health visits using an electronic medical record template was effective at reducing inappropriate Pap testing • The Future: Data re-analysis for broader efficacy once all trainees have rotated through the clinic • Implication: creating electronic medical record templates and focusing women’s health visits may prove to be an effective way to improve compliance with Pap testing guidelines in primary care
  • 14. Slide 14 Questions? THE WALL STREET JOURNAL 2/15/2011 “Questioning the Need For Routine Pelvic Exam” By Melinda Beck “Of all the indignities that women endure in their lives, one of the most dreaded is the routine pelvic exam.” -Based on commentary Journal of Women’s Health -Article makes reference to the new ACOG guidelines recommending Pap every 2 years for women age 21 to 30 and 3 years 30 for older

Editor's Notes

  1. As background, there has been much attention recently devoted to the fact that guideline-inconsistent cancer screening is prevalent. A survey published in Annals regarding Pap testing found that despite physician commitment to guidelines, a very low percentage of providers were guideline consistent in their recommendations across clinical vignettes. -Internists were only guideline consistent across all vignettes for Pap screening 27.5% of the time This problem was also evident in recent research regarding colorectal cancer screening -Investigators noted both overuse and underuse of screening with only 19.1% of providers guideline consistent recommendations across all colorectal cancer screening modalities
  2. With the recent research and attention to guidelines, we turned to our own internal medicine resident clinic at the VCU ambulatory care center pictured to the right. The VCU internal medicine resident clinic is staffed by both internal medicine and med/peds residents who maintain their own patient panel and see patients 1/2 day per week. Patients served come from both urban and rural settings throughout a broad distance in southern Virginia Patients are largely medically underserved and often under or non-insured
  3. With regard to our own clinic and adherence to cancer screening guidelines, we noted a tendency to over-screen patients for cervical cancer. Much of the confusion about cervical cancer screening stems from the multiple sources of often conflicting guidelines. The principle sources of Pap testing guidelines include the American College of Obstetrics and Gynecology as well as the U.S. Preventive Services Task Force and the American Cancer Society. The conflicting recommendations from these three sources often contribute to confusion among providers. Residents are likely aware of all three of the major sources of guidelines based on their medical school training. The fact that students are trained in pap testing on family medicine, internal medicine, and OB/gyn rotations renders them especially vulnerable
  4. Suspecting that our residents were vulnerable to confusion about cervical cancer screening and noting a tendency toward overscreening in our own clinic, we began a retrospective chart review including 229 patients who underwent Pap testing between February of 2004 and December of 2009. Appropriateness of Pap tests was based on USPSTF guidelines for cervical cancer screening On the left, you’ll note that we conducted inappropriate pap tests 17% of the time (n=39; mean age 60.3, SD +/- 10.3 years). On the right you’ll see that out of the inappropriate tests, 79.5% were performed on women post hysterectomy for a non-malignant cause, 12.9% on women &amp;gt; age 65 without risk factors, and 7.7% on women &amp;gt; age 65 who also had a hysterectomy for non-malignant cause.
  5. Our aim was to design and implement an intervention to improve residents understanding of guidelines and their adherence to guidelines with regard to the appropriate use of Pap testing. We hypothesized that we would achieve 95% adherence to USPSTF cervical cancer screening guidelines
  6. Our intervention plan created a “Pap Clinic” held 1/2 day per week, staffed by 2 interns, a women’s health resident, and an attending. Essential components to the plan for our clinic were to allow for focused women’s health visits and to design an appropriate electronic medical record template to help with these focused visits Key components to the electronic medical record template Highlights relevant GYN history to prompt the questions needed to ascertain appropriateness of a Pap smear (repetitively and methodically collect the necessary information to determine if pap testing is appropriate 2. Incorporates a brief version of the USPSTF guidelines themselves (visual reminder of guidelines repetitively) 3. Interns were advised to include in their plan why they did/did not perform Pap testing and a recommendation regarding the appropriate interval for screening to inform the referring providers
  7. In our pilot study, 229 charts were reviewed for appropriateness of Pap testing with a result of 17% inappropriate testing. Instituted the Pap Clinic Subsequently, we reviewed 119 charts from our “Pap Clinic” between February 2009 and July 2010 Criteria for appropriateness were the same pre and post-intervention We conducted univariate and bivariate analyses with means, Fisher exact, and ANOVA tests We used SAS 9.2 statistical software and a p-value &amp;lt;0.05 was considered statistically significant
  8. Demographic information was collected during the pilot study and post-intervention to analyze for differences with regard to age, race, and insurance status. You’ll note that there were no significant differences between the initial study group and the post-intervention characteristics. Note that the average age was not substantially different between our pilot study patients and the post-intervention group. Similarly, the ethnic breakdown of patients was not significantly different with the majority of patients being African-American Finally, the percentage insured by either medicare or private insurance was not substantially different (55% vs. 50.5%)
  9. You’ll remember that in our pilot study, 17% of Pap tests performed in our clinic were inappropriate by USPSTF guidelines with the vast majority (79.5%) done on women who were post-hysterectomy for benign reasons. On the right hand side of the screen, you’ll see that post-intervention there was a statistically significant decrease in inappropriate Paps based on USPSTF guidelines. We were able to achieve our goal 95% adherence to USPSTF guidelines with only 1.7% inappropriate tests, both of which were performed on women. Both of the inappropriate tests in our post-intervention group were done on patients who were too old and post-hysterectomy for benign reasons.
  10. Results may lack generalizability both in terms of the demographics and complexity of our patient population (majority are african american and underinsured), as well results may be more robust in the setting of medical education because interns are more easily molded by intervention than experienced practitioners Both of these facts may mean that results are not generalizable to other clinics and practice settings Our post-intervention data is subject to selection bias in that only Pap smears performed in the Pap clinic were analyzed post-intervention We may be over-estimating our intervention effect size based on our small sample size post-intervention. Given the simplicity of our intervention, we were willing to over-estimate our treatment effect size and tolerate a large Type I error It is still too early to assess for the overall effect of our intervention. At present, the first interns to rotate through the Pap Clinic are still second years. -Note that we still have 16.8% inappropriate referral